Momenta Pharmaceuticals, Inc. (MNTA)

[jb_118]

Can we temporarily readjust expenses (temporarily cut expenses on M118 and M302) until we launch Copaxone and use those 100m savings instead to buy up 15% of company's stock at current price of $11

What if copaxone never gets approved and they've blown their cash buying back shares and stalling the rest of the pipeline, which means laying off the people working on it? It's so so foolish.

Biotech companies sell hope. The pipeline is the hope. MNTA's problem isn't too many shares, it's poor resolution on the pipeline. Stalling out the pipeline is crazy.

They aren't moving M118 forward themselves anyway. And it's M402, not M302.